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Abstract
Introduction: Acute Rheumatic Fever and Post Streptococcal Reactive Arthritis in adults can
present in a similar manner.
Case Presentation: A 25 year old Caucasian male developed a transient crippling polyarthritis
one month following treatment of a sore throat. The patient was found to meet criteria for both
Acute Rheumatic Fever and Post Streptococcal Reactive Arthritis, leading to the question of the
role of antibiotic prophylaxis long term.
Conclusion: Due to overlap in the diagnostic criteria for Acute Rheumatic Fever and Post
Streptococcal Reactive Arthritis in adults, the need for penicillin prophylaxis should be
individualized based on exposure risk.
Background
Acute Rheumatic Fever is a disease state described since
the 1800s. It is found most commonly in children, and
the disease can manifest in a variety of ways. ARF can
present with migratory arthritis involving primarily the
large joints, carditis and valvulitis, central nervous system
involvement, rash, or any combination of these. These
reactions are the sequelae of a pharyngeal infection with
group A streptococcus [1].
The Jones criteria were established in 1944 and revised as
recently as in 1992 to help make the diagnosis of ARF. The
major criteria include carditis, polyarthritis, chorea, ery-
thema marginatum, and subcutaneous nodules. The
minor criteria include arthralgia, fever, elevated erythro-
cyte sedimentation rate, elevated C-reactive protein, or a
prolonged PR interval [1]. For diagnosis of ARF, the pres-
ence of two major or one major and two minor manifes-
tations and evidence of a preceding group A streptococcal
infection is required. A positive throat culture for group A
beta-hemolytic streptococci, positive rapid streptococcal
antigen test, or elevated or rising streptococcal antibody
titer are all acceptable [1].
The treatment for Acute Rheumatic Fever involves antibi-
otic therapy and anti-inflammatory agents. The use of
antibiotic therapy with penicillin is recommended for the
treatment of the streptococcal infection, while antibiotic
prophylaxis with penicillin, sulfadiazine, or erythromycin
is recommended in order to prevent the recurrence of
ARF. Anti-inflammatory agents, are used to treat the
inflammatory manifestations, and generally produce a
dramatic improvement in symptoms at the onset of treat-
ment [1].
The literature cites cases where arthritis following a strep-
tococcal infection was not due to Acute Rheumatic Fever.
These cases have been given the diagnosis of Post-Strepto-
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coccal Reactive Arthritis (PSReA), first described in 1982
and seen mainly in adults. These patients generally pre-
sented with only arthritis, occurring up to ten days after an
episode of a streptococcal infection, compared with the
average of twenty-one days seen in ARF [2]. They experi-
enced prolonged or recurrent arthritis, lasting an average
of two months. The arthritis seen in ARF, in contrast, is
found to last one to five days with complete resolution in
three weeks [2,3]. PSReA is unresponsive to aspirin or
other nonsterioidal medications. Furthermore, extra-artic-
ular manifestations, such as tenosynovitis, are often seen
in these patients, whereas cardiac involvement is not [2-
4].
In children PSReA is readily distinguished from ARF due
to the presence of other major Jones Criteria. In adults,
differentiating between the two diseases is not as clear.
Some patients diagnosed with PSReA also fulfill the one
major and two minor criteria for ARF [5]. In regard to
treatment the major difference between the two disease
states is that antibiotic prophylaxis is not recommended
in adults diagnosed with PSReA due to lack of evidence of
progression to ARF or development of cardiac sequelae,
where it is required in the management of ARF [2].
Case Presentation
A 25 year old male presented with two weeks of pain and
swelling in his knees and ankles. The symptoms began in
his right knee, after he experienced minor trauma. He
sought emergency room care and was discharged home
on ibuprofen after x-rays were negative. The pain and
swelling then gradually spread to his left knee and right
ankle. At a follow up orthopedic visit medication was con-
tinued. His symptoms worsened and impeded his ability
to walk.
On day of admission, the patient also complained of new
onset of some left MCP and DIP joint tenderness. He
denied fevers, chills, shortness of breath, or headaches,
but described progressive fatigue over a few weeks. He
reported a sore throat six weeks prior, which was treated
with amoxicillin for seven days. This was followed by
diarrhea which resolved in one week. He was born in the
United States, had no medical or surgical history, and no
significant family history. He denied the use of cigarettes,
alcohol, or illicit drugs. He stated he was currently sexu-
ally active with other men. There was no recent travel his-
tory, or sick contacts. He worked as a first grade school
teacher.
On physical exam the patient had a temperature of
100.6F, synovitis and effusions in both knees L>R; right
ankle and fifth DIP showed periarticular involvement
(Figure 1), tenosynovitis and there was swelling over the
dorsum of the left hand. All involved joints were ery-
thematous and exquisitely tender with a decreased range
of motion. There was no evidence of a rash, spine tender-
ness or cardiac murmur.
CBC demonstrated a WBC count of 16.4 (84% polys),
platelet count of 1084K, and the ESR was 115. Knee
arthrocentesis yielded cloudy yellow fluid (WBC 7,350
with 56% polys), with negative cultures. HIV, urethreal
Gonococcal and Chlamydia testing, Rheumatoid Factor,
ANA, C. difficile toxins, blood cultures, stool cultures, and
throat cultures were negative. The ASLO titer was elevated
at 518 (normal <200). EKG demonstrated sinus tachycar-
dia, with a normal PR interval. A transthoracic echocardi-
ogram was unremarkable.
Despite Sulindac 200 mg orally twice daily, the patient's
symptoms persisted and a taper of prednisone starting at
40 mg/d orally was required for relief. After discharge he
continued to respond well to corticosteroid therapy, and
regained strength.
Discussion
The patient fulfilled the modified Jones criteria for ARF
(major: arthritis; minor: fever and elevated ESR), without
fitting the typical disease presentation. He also fits many
of the criteria for PSReA: adult, arthritis > 3 weeks, no car-
ditis, poor response to NSAID therapy, and absence of
other major Jones criteria [5]. As reviewed above, it is dif-
ficult to distinguish ARF from PSReA, but necessary in
determining the need for antibiotic prophylaxis. This
patient would likely be exposed to streptococcus again
due to his occupation as a teacher of young children, so
Periarticular involvement Figure 1
Periarticular involvement. Photograph demonstrating 
periarticular involvement of patient's fifth DIP on the left 
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our clinical judgment led us to place him on penicillin
prophylaxis for at least five years.
Conclusion
This case exemplifies the overlap between the diagnostic
criteria of Acute Rheumatic Fever, and Post Streptococcal
Reactive Arthritis. Although these cases are far less com-
mon today, they should still be on the differential diagno-
sis in a patient with arthritis and fever. In an ambiguous
case such as this, it is prudent to individualize the antibi-
otic prophylaxis based on occupational risk or lifestyle.
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